| Item | Property | Value | Comments |
|---|
 include | http://snomed.info/sct | | http://snomed.info/sct/2011000195101 | |
 Concept | 42284007 | Administration of vaccine product containing only live attenuated Mycobacterium bovis antigen (procedure) | |
| Concept | 76668005 | Administration of vaccine product containing only Corynebacterium diphtheriae antigen (procedure) | |
| Concept | 127787002 | Administration of vaccine product containing only Haemophilus influenzae type B antigen (procedure) | |
| Concept | 243789007 | Administration of vaccine product containing only Hepatitis A virus antigen (procedure) | |
| Concept | 16584000 | Administration of vaccine product containing only Hepatitis B virus antigen (procedure) | |
| Concept | 86198006 | Administration of vaccine product containing only Influenza virus antigen (procedure) | |
| Concept | 314759000 | Administration of vaccine product containing only Japanese encephalitis virus antigen (procedure) | |
| Concept | 47435007 | Administration of vaccine product containing only Measles morbillivirus antigen (procedure) | |
| Concept | 719596001 | Administration of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) | |
| Concept | 314417000 | Administration of vaccine product containing only Neisseria meningitidis serogroup A and C antigens (procedure) | |
| Concept | 871874000 | Administration of vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y antigens (procedure) | |
| Concept | 50583002 | Administration of vaccine product containing only Mumps orthorubulavirus antigen (procedure) | |
| Concept | 761841000 | Administration of vaccine product containing only Human papillomavirus antigen (procedure) | |
| Concept | 39343008 | Administration of vaccine product containing only Bordetella pertussis antigen (procedure) | |
| Concept | 1119368005 | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 4, 6B, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated (procedure) | |
| Concept | 1119366009 | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens (procedure) | |
| Concept | 1119367000 | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens (procedure) | |
| Concept | 72093006 | Administration of vaccine product containing only Human poliovirus antigen (procedure) | |
| Concept | 34631000 | Administration of vaccine product containing only Rabies lyssavirus antigen (procedure) | |
| Concept | 82314000 | Administration of vaccine product containing only Rubella virus antigen (procedure) | |
| Concept | 127786006 | Administration of vaccine product containing only Clostridium tetani antigen (procedure) | |
| Concept | 281658005 | Administration of vaccine product containing only Tick-borne encephalitis virus antigen (procedure) | |
| Concept | 15483003 | Administration of vaccine product containing only Salmonella enterica subspecies enterica serovar Typhi antigen (procedure) | |
| Concept | 737081007 | Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure) | |
| Concept | 722215002 | Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for shingles (procedure) | |
| Concept | 67308009 | Administration of vaccine product containing only Yellow fever virus antigen (procedure) | |
| Concept | 1157107003 | Administration of vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (procedure) | |
| Concept | 1119350007 | Administration of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure) | |
| Concept | 1209198003 | Administration of vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigen (procedure) | |
 Concept | 1162645008 | Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure) | |
| Code | Display | Comments |
|---|
| 42284007 | Administration of vaccine product containing only live attenuated Mycobacterium bovis antigen (procedure) | |
| 76668005 | Administration of vaccine product containing only Corynebacterium diphtheriae antigen (procedure) | |
| 127787002 | Administration of vaccine product containing only Haemophilus influenzae type B antigen (procedure) | |
| 243789007 | Administration of vaccine product containing only Hepatitis A virus antigen (procedure) | |
| 16584000 | Administration of vaccine product containing only Hepatitis B virus antigen (procedure) | |
| 86198006 | Administration of vaccine product containing only Influenza virus antigen (procedure) | |
| 314759000 | Administration of vaccine product containing only Japanese encephalitis virus antigen (procedure) | |
| 47435007 | Administration of vaccine product containing only Measles morbillivirus antigen (procedure) | |
| 719596001 | Administration of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) | |
| 314417000 | Administration of vaccine product containing only Neisseria meningitidis serogroup A and C antigens (procedure) | |
| 871874000 | Administration of vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y antigens (procedure) | |
| 50583002 | Administration of vaccine product containing only Mumps orthorubulavirus antigen (procedure) | |
| 761841000 | Administration of vaccine product containing only Human papillomavirus antigen (procedure) | |
| 39343008 | Administration of vaccine product containing only Bordetella pertussis antigen (procedure) | |
| 1119368005 | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 4, 6B, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated (procedure) | |
| 1119366009 | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens (procedure) | |
| 1119367000 | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens (procedure) | |
| 72093006 | Administration of vaccine product containing only Human poliovirus antigen (procedure) | |
| 34631000 | Administration of vaccine product containing only Rabies lyssavirus antigen (procedure) | |
| 82314000 | Administration of vaccine product containing only Rubella virus antigen (procedure) | |
| 127786006 | Administration of vaccine product containing only Clostridium tetani antigen (procedure) | |
| 281658005 | Administration of vaccine product containing only Tick-borne encephalitis virus antigen (procedure) | |
| 15483003 | Administration of vaccine product containing only Salmonella enterica subspecies enterica serovar Typhi antigen (procedure) | |
| 737081007 | Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure) | |
| 722215002 | Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for shingles (procedure) | |
| 67308009 | Administration of vaccine product containing only Yellow fever virus antigen (procedure) | |
| 1157107003 | Administration of vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (procedure) | |
| 1119350007 | Administration of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure) | |
| 1209198003 | Administration of vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigen (procedure) | |
| 1162645008 | Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure) | |